**Core Concept**
Carcinoma of the cheek, also known as oral squamous cell carcinoma, is a type of head and neck cancer that requires effective treatment strategies. In the context of chemotherapy, the goal is to administer a single drug that can target cancer cells and induce cell death while minimizing harm to normal tissues.

**Why the Correct Answer is Right**
Cisplatin is a platinum-based chemotherapy drug that has been widely used to treat various types of cancers, including head and neck cancers. It works by forming platinum-DNA adducts, which interfere with DNA repair mechanisms and induce apoptosis (programmed cell death) in cancer cells. Cisplatin's efficacy in treating carcinoma of the cheek is attributed to its ability to target rapidly dividing cancer cells and its relatively favorable toxicity profile compared to other chemotherapy agents.

**Why Each Wrong Option is Incorrect**
**Option A:** Cyclophosphamide is an alkylating agent used primarily in the treatment of lymphomas and breast cancer. It is not the preferred choice for treating carcinoma of the cheek.
**Option B:** Vincristine is a vinca alkaloid that inhibits microtubule formation, thereby disrupting cell division. While it is used in the treatment of various cancers, it is not the most effective single-agent chemotherapy for carcinoma of the cheek.
**Option C:** Daunorubicin is an anthracycline antibiotic that intercalates DNA, thereby inhibiting topoisomerase II and inducing apoptosis. Although it is used in the treatment of leukemia and other cancers, it is not the preferred choice for treating carcinoma of the cheek.

**Clinical Pearl / High-Yield Fact**
Cisplatin-based chemotherapy regimens often include other agents, such as 5-fluorouracil (5-FU) and radiotherapy, to enhance treatment efficacy and reduce toxicity. The combination of cisplatin and 5-FU has been shown to improve overall survival and disease-free survival in patients with carcinoma of the cheek.

**✓ Correct Answer: D. Cisplatin**